Our Mission
Who We Are
EmeritusDX is a cancer diagnostics company that is driven by our obsession to continuously improve patient care. Within our CLIA certified laboratory, our expertise is in delivering diagnostic laboratory services as well as effectively supporting the custom research and clinical trial markets. Our common mission is to save lives one specimen at a time. We value the relationships with our clients and partners and work tirelessly to build trust. Together, we work to solve the medical, scientific, and logistical dilemmas of making precise diagnoses, enabling new therapies to become available and carving the pathway towards improving patient care.
What We Do
We provide expert surgical pathology consults supported by an extensive IHC antibody library. Our first class FISH department helps ensure more tools are available in reaching a definitive diagnosis. Additionally, we offer technical-only testing platforms that are available to pathologists who wish to interpret their own FISH and/or IHC cases. Our Research and Pharma services team offer all of these methodologies along with flexibility and customization in order to meet the rapidly evolving needs of our partners. By leveraging our expertise, flexibility, and innovation we consistently exceed expectations of our partners in the oncology market segment. Our partners include hospital and private pathology laboratories, biotechnology companies, academic institutions, contract research and pharmaceutical development organizations, and more.
Why It Is Important
We believe people fighting cancer need access to the necessary tools to overcome their battle. At EmeritusDX we firmly believe it is our responsibility through diagnostic service, as well as test and drug development, to improve the outcome for cancer patients. Our team is dedicated to scientific excellence and being a reliable partner in the drive towards improving patient care. Our service revolves around the patient and the quest towards precision medicine. We understand the dependency on our accurate and timely results and our commitment to excellence in this regard is unwavering.